Corium to Present at Upcoming Healthcare Investor Conferences
MENLO PARK, Calif. , Feb. 06, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that the company will be participating in…